| Q45031690 | 24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. |
| Q35206483 | Acute coronary ischemia during alcohol withdrawal: a case report |
| Q90615433 | Acute inferior ST-elevation myocardial infarction due to delirium tremens: a case report |
| Q55006460 | Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition. |
| Q36666016 | Adrenergic Inhibition with Dexmedetomidine to Treat Stress Cardiomyopathy during Alcohol Withdrawal: A Case Report and Literature Review |
| Q35146112 | Alcohol and withdrawal: from animal research to clinical issues |
| Q34283144 | Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms |
| Q38698139 | Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment |
| Q72777212 | Alcoholism |
| Q91667132 | Alcoholism Treatment in the United States |
| Q37800585 | An Approach to the Patient with Substance Use and Abuse |
| Q28243981 | Antagonism of ethanol intoxication in rats by inhibitors of phenylethanolamine N-methyltransferase |
| Q67657531 | CSF galanin in alcoholics, pathological gamblers, and normal controls: A negative report |
| Q51073054 | Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being? |
| Q36145071 | Cellular and molecular physiology of alcohol actions in the nervous system |
| Q46690356 | Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism |
| Q72079719 | Circadian variation in plasma 5‐hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects |
| Q42073585 | Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients |
| Q71652902 | Circadian variations in plasma monoamine metabolites level in alcoholic patients: A possible predictor of alcohol withdrawal delirium |
| Q51590650 | Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. |
| Q28295614 | Current Approaches to the Recognition and Treatment of Alcohol Withdrawal and Delirium Tremens: “Old Wine in New Bottles” or “New Wine in Old Bottles” |
| Q42574905 | Delirium in the ICU: an overview |
| Q73947175 | Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat |
| Q38131455 | Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research |
| Q51538142 | Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. |
| Q34985988 | Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism |
| Q48097277 | Effect of cigarette smoking on ACTH/cortisol secretion in alcoholic after short- and medium-term abstinence |
| Q41113725 | Effects of age and alcoholism on the prevalence of panic disorder |
| Q48243215 | Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure |
| Q45153293 | Effects of venlafaxine on ethanol withdrawal syndrome in rats. |
| Q48888985 | Electrophysiological effects of ethanol on monoaminergic neurons: an in vivo and in vitro study |
| Q48537232 | Evidence for altered central noradrenergic function in experimental acute liver failure in the rat. |
| Q44292711 | Extremely long recovery time for the sedative effect of clonidine in male type 1 alcohol-dependent subjects in full sustained remission |
| Q48960781 | Hypothalamic-pituitary and thyroid function in chronic alcoholics with neurological complications |
| Q48147287 | Hypothalamic-pituitary-thyroid axis in chronic alcoholism. II. Deiodinase activities and thyroid hormone concentrations in brain and peripheral tissues of rats chronically exposed to ethanol. |
| Q36589149 | Identification and treatment of alcohol use disorders in the perioperative period |
| Q40379570 | Impaired oxygen utilization. A new mechanism for the hepatotoxicity of ethanol in sub-human primates |
| Q48894726 | Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide—induced acute liver failure |
| Q48409713 | Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala |
| Q34135604 | Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal |
| Q37381240 | Ketoacidosis in a Non-Diabetic Adult With Chronic EtOH Consumption |
| Q22305841 | Managing Alcohol Withdrawal in the Elderly |
| Q26778030 | Morphine for Intravenous Patient-Controlled Analgesia May Inhibit Delirium Tremens: A Case Report and Literature Review |
| Q73784063 | Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats |
| Q92754486 | Multiple electrolyte imbalances and mixed acid-base disorder posing a diagnostic dilemma: a case report |
| Q37414960 | Pharmacotherapies for alcoholism: promising agents and clinical issues |
| Q44080831 | Plasma catecholamines in ethanol tolerance and withdrawal in mice |
| Q72561833 | Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures |
| Q28074617 | Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review |
| Q51644042 | Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. |
| Q50137470 | Relating acoustic startle reactivity and plasticity to alcohol consumption in male Wistar rats |
| Q68102830 | Responding to acoustic startle during chronic ethanol intoxication and withdrawal |
| Q43661726 | Reversibility of alcohol-induced immune depression |
| Q37869277 | Role of α2-agonists in the treatment of acute alcohol withdrawal |
| Q35574078 | Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management |
| Q37432409 | Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse |
| Q33969995 | Substance abuse and withdrawal in the intensive care unit. Contemporary issues |
| Q48874043 | The alcohol withdrawal "kindling" phenomenon: clinical and experimental findings |
| Q38669841 | The treatment of alcohol withdrawal |
| Q51565913 | The urinary MHPG/creatinine ratio and its relationship to platelet monoamine oxidase activity in abstinent alcoholics. |
| Q36203950 | Update on Delirium |
| Q48715825 | Urine melatonin in alcoholic patients: a marker of alcohol abuse? |
| Q41132236 | Yohimbine can induce ethanol tolerance in an in vitro preparation of rat locus coeruleus |